Ibandronate Sodium
Product Images NDC 60505-2795

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 60505-2795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ibandronate-01 (Ibandronate 01)

Chemical structure diagram of ibandronate sodium showing its molecular components including nitrogen, phosphate groups, hydroxyl group, and a propanol side chain.*

FDA Label Image

Image-01.jpg (Image 01)

Packaging label for Ibandronate Sodium Tablet 150 mg by Apotex Corp, NDC 60505-2795-0. The label indicates the tablet is taken once monthly for osteoporosis therapy and includes storage instructions and pharmacist dispensing guidance. The carton also features illustrated instructions for opening the blister card and child-resistant unit dose packaging details.*

FDA Label Image

Instructions1.jpg (Instructions1)

An instructional illustration showing a person using their thumb and index finger to perform a twisting or opening motion on a container or packaging. The image highlights the action with an arrow indicating the direction of rotation.*

FDA Label Image

Instructions2.jpg (Instructions2)

An instructional illustration showing a hand pressing a blister pack tablet with an arrow indicating the direction to push the tablet through the packaging. This image is likely demonstrating how to remove a tablet from the blister pack.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.